Fig. 6From: Prognostic risk assessment model and drug sensitivity analysis of colon adenocarcinoma (COAD) based on immune-related lncRNA pairsAnalysis of drug sensitivity. CCT007093, Embelin, PAC1, and Rapamycin were the most sensitive (p-value < 0.001). ABT.263, AZD.0530, IPA.3, Lenalidomide, Nilotinib, PLX4720 were relatively sensitive (p-value < 0.01)Back to article page